An Evaluation of the Effect of the Erchonia FX-405 Laser as an Adjunctive Treatment of Periodontitis

Recruiting now · Not applicable · Has a placebo group

Conditions studied: Periodontal Diseases, Periodontitis, Gum Disease

In brief

The purpose of this clinical study is to determine the effectiveness of the Erchonia® FX-405 (manufactured by Erchonia Corporation (the Company) in providing a noninvasive adjunctive treatment in combination with periodontal scaling and root planing for improving the treatment of periodontal disease.

Key facts

Study ID: NCT06656325
Run by: Erchonia Corporation
People needed: 70
Starts: 2025-01-01
Expected to finish: 2027-08-01
Last updated by the study team: 2026-05-18

Who can join

Age: 22 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

Subject has voluntarily signed a written informed consent form.
Male or female 22 to 75 years of age, inclusive.
Subject has no evidence of Localized Aggressive Periodontitis.
Tooth loss due to periodontitis of ≤ 4 teeth.
Two or more teeth with the following characteristics: Non 3rd molar, Periodontitis: Stage III (Severity) according to the Interdental CAL (at site of greatest loss) and RBL, as classified by the American Academy of Periodontology (AAP), No evidence of caries, No abscess infection, No previous periodontal surgery within the prior 12 months
Subject agrees to adhere to study provided home care instructions to maintain adequate oral hygiene during the study duration.
Subject agrees to refrain from the use of smokeless chewing tobacco for the study duration.
Subject agrees to refrain from exceeding 40 milligrams per day of inhaled nicotine, encompassing cigarettes, electronic cigarettes, and cigars.
Subject agrees to refrain from engaging in any other treatments for his or her periodontitis that is outside the scope of this study during his or her participation in this study

You may not qualify if…

Gingival recession which may be genetic, induced secondary to orthodontic treatment, induced secondary to frenulum attachments, or present as a result of dental malocclusion.
History of oral cancer or HIV in the last 6 months
Pregnant or intending to become pregnant in the next 8 months.
Sensitivity to, or contraindication for, light therapy.
Currently enrolled in a clinical study of an investigational drug or device.

Where it is running

805 Dentistry — Thousand Oaks, California, United States (enrolling)
Acton Dental Associates — Acton, Massachusetts, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.